GIPR is expressed in adipose tissue, bone, and the central nervous system, particularly in brain regions involved in reward processing and energy homeostasis
A cross-sectional study in Sweden showed that a lack of social support was one of the biggest obstacles to long-term weight loss
Genetic Factors and Personalized Safety Assessment Individual genetic variation affects how bodies respond to GLP-1 therapy, influencing both efficacy and safety profiles
GLP-1 medications like semaglutide have transformed weight loss outcomes for millions, but pregnancy changes the safety equation entirely
Other red flags: uncontrollable vomiting , inability to keep fluids down, worsening weakness or dehydration
It can also be prescribed for those who are overweight, with a BMI of 27 or higher, if they also have at least one weight-related health condition